Additionally, the absence of exon IV in TCF7L1 transcripts has been linked to high risk of hepatic cancer (Tomimaru et al., 2013), while exon IV absence in TCF7L2 is associated with higher risk of type 2 diabetes (Pradas‐Juni et al., 2014). Here, TCF7L1 is linked to type 2 diabetes mellitus.